Figure 4From: Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease: attrition rate and evolution of disease activityKaplan-Meier plot showing therapy survival over time for patients discontinuing infliximab due to safety issues.Back to article page